20/09/10

Stakeholder Comments Form

‘Report on Study of Measurement Service and Comparison Needs for an International Measurement Infrastructure for the Bioscience and Biotechnology: Input for the BIPM Work Programme’

This study was commissioned by the BIPM and delivered by LGC under contract in responseto the call for tender number AO/BIPM/CHIM/2009/015.The key aim of the study was to provide a Report on:

  1. Measurement services required to establish an International Measurement Infrastructure for the Biosciences that:
  2. Are expected to be delivered and/or developed in the next 3-5 years and 5-10 years by NMIs, or other organisations developing measurement standards, or methods for the biosciences
  3. Are required by industry and other identified stakeholders over the next 3-5 and 5-10 years
  1. International comparisons that are required to demonstrate the degree of equivalence of the measurement services that are, or will be developed and delivered
  1. R&D activities necessary for the development of higher metrological order measurement standards and methods for the biosciences

The Study focused on protein and nucleic acid measurements for healthcare, which were identified as fields of high interest by the BIPM at the start of the Study.

The report will provide input for BIPM proposals on future requirements for BIPM laboratory activities in Metrology for Biotechnology and the Biosciences and is intended to be a useful reference for National Measurement Institutes developing programmes in these fields.

The BIPM welcomes comments on the Draft Report, which will be considered and taken into account in the Final Report. A Form to help structure any comments is given overleaf.

Please forward your comments by 30November 2010 to:

John Marriott, LGC

Email:

Thank you,

John Marriott

LGC

Study Project Manager

Name
Affiliation
Country
Tel.
Email
Section 2: Review of Roadmaps and Strategies
Q2.1: Have any significant Roadmaps or Strategies relating to measurement in the bioscience field been omitted?
Q2.2: Are there any other significant measurement service requirements needed over the next 10 yr. which have not been identified?
Q2.3: Any other comment on Section 2?
Section 3: Review of BAWG Strategy
Q3.1: Has any important element of the BAWG Strategy been omitted?
Q3.2: Any other comment on Section 3?
Section 4: Interviews with Measurement Institutes
Q4.1: Did the measurement institutes interviewed represent a comprehensive selection of those undertaking work in bio-measurement?
Q4.2: Have the key measurement services and comparison needs of the Institutes for proteins and nucleic acids over the next 10 yr. been identified?
Q4.3: Any other comments on Section 4?
Section 5: Measurement Needs of Industry and Regulator’s Comments
Q5.1: Has the Report identified the main needs of the Diagnostics industry for higher metrological order measurement services?
Q5.2: Has the Report identified the main needs of the Bio-pharmaceutical industry for higher metrological order measurement services?
Q5.3: Any other comment on Section 5?
Section 6: Analysis
Q6.1: Did the Analysis identify the major categories of protein measurement which are of interest to the NMIs in developing measurement services to support the comparability of these measurements?
Q6.2: Did the Analysis identify the main future measurement services for proteins to be provided by the NMIs?
Q6.3: Did the Analysis identify the main international comparisons needed to help ensure the global comparability of protein measurements?
Q6.4: Did the Analysis identify the main areas of collaborative R&D needed to develop the protein measurement services for the long-term?
Q6.5: Did the Analysis identify the major categories of nucleic acid measurement which are of interest to the NMIs in developing measurement services to support the comparability of these measurements?
Q6.6: Did the Analysis identify the main future measurement services for nucleic acids to be provided by the NMIs?
Q6.7: Did the Analysis identify the main international comparisons needed to help ensure the global comparability of nucleic acid measurements?
Q6.8: Did the Analysis identify the main areas of collaborative R&D needed to develop the nucleic acid measurement services for the long-term?
Q6.9: Any other comments on Section 6?
Section 7: Conclusions
Q7.1: Have the main areas of work for protein and nucleic acid measurements which are likely to have significant strategic and underpinning value in ensuring the comparability of these measurements been identified?
Q7.2: Any other comment on the Conclusions?
General Comments
Q8.1: Any other comment on the Report, or corrections needed?